🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Ovarii › Texas › Austin

Qorannoo klinikaalii Kansarii Ovarii Austin, TX keessatti

Qorannoo 17 Kansarii Ovarii f Austin fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Austin, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06270706

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Namoota walitti qabaa jiraSadarkaa 1/2
  • New Experimental Therapeutics - NEXT Oncology, Austin
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Oncology, Austin
Umuriin 19 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06586957

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Namoota walitti qabaa jiraSadarkaa 2
  • Texas Oncology-Austin North /ID# 279958, Austin
Umuriin 18 fi ol · Dubartoota · Haaromfame 01-Onk-2026 · NCT07024784

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • USO-Texas Oncology-Central/South Texas, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07213804

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Namoota walitti qabaa jiraSadarkaa 2
  • Texas Oncology-Austin Center, Austin
Umuriin 18 hanga 99 · Dubartoota · Haaromfame 15-Ful-2026 · NCT07023627

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Namoota walitti qabaa jiraSadarkaa 3
  • Texas Oncology - Central/South Texas ( Site 8009), Austin
Umuriin 18 fi ol · Dubartoota · Haaromfame 03-Ful-2026 · NCT06824467

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Oncology - Austin, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07444814

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Texas Oncology - Central / South Texas, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT05579366

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Texas Oncology - Central/South Texas, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT04657068

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Texas Oncology - Central South, Austin
Umuriin 18 fi ol · Dubartoota · Haaromfame 16-Elb-2026 · NCT05659381

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Oncology Austin, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Elb-2026 · NCT07424547

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Elligo Health Research, Inc., Austin
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT05366881

Sample Collection for Ongoing Research and Product Evaluation Study

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Natera, Inc., Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ama-2026 · NCT07318051

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Namoota walitti qabaa jiraSadarkaa 1
  • Dren Investigational Site, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ama-2026 · NCT06999187

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Exelixis Clinical Site #4, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Ful-2025 · NCT05932862

Qorannoo Kansarii Ovarii magaalota biroo keessatti

Qorannoo biroo Austin keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.